Gut microbiota as a prognostic biomarker for unresectable hepatocellular carcinoma treated with anti-PD-1 therapy
The enrichment of specific gut microbiota affected clinical efficacy and survival benefits in HCC treated with anti-PD-1 therapy and may be a promising non-invasive gut microbial biomarker and a new strategy for modulating immunotherapy in HCC.
Authors
- Xiaojing Cao
- Yujing Xin
- Wei Song (ORCID: https://orcid.org/0000-0002-7007-5281)
- Xiang Zhou (ORCID: https://orcid.org/0000-0003-0935-8175)
- Gang Peng (ORCID: https://orcid.org/0000-0002-2167-9484)
- Xiaoyu Huang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2024-10-03
- DOI
- https://doi.org/10.3389/fgene.2024.1366131
- Citations
- 9
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.54
Funders
- National Natural Science Foundation of China